Mycobacteria tuberculosis peritonitis associated with etanercept therapy

Clin Exp Rheumatol. Jul-Aug 2003;21(4):526.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use
  • Arthritis, Juvenile / diagnosis
  • Arthritis, Juvenile / drug therapy*
  • Biopsy, Needle
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Etanercept
  • Female
  • Follow-Up Studies
  • Humans
  • Immunocompromised Host
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Immunohistochemistry
  • Mycobacterium tuberculosis / isolation & purification*
  • Peritonitis / drug therapy
  • Peritonitis / immunology
  • Peritonitis / microbiology*
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Risk Assessment
  • Treatment Outcome
  • Tuberculosis, Gastrointestinal / diagnosis*
  • Tuberculosis, Gastrointestinal / drug therapy
  • Tuberculosis, Gastrointestinal / immunology

Substances

  • Antitubercular Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept